Inventor · disambiguated record
Soren Ottosen
Also filed as: OTTOSEN SOREN
4 granted patents·5 pending applications·4 citations·filing 2013–2025
63Inventor score
Top patents by PatentIndex Score
9 records- 0190US12303525B2Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infectionHOFFMANN LA ROCHE·Filed 2022·Granted May 20, 2025·1 cites·41 claims
- 0277US2023210887A1Nucleic acid molecules for reduction of papd5 or papd7 mrna for treating hepatitis b infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0375US2025319114A1NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTIONHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0473US9725723B2Compositions and methods for modulation of FGFR3 expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2013·Granted Aug 8, 2017·3 cites·14 claims
- 0567US2024150758A1Use of fubp1 inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0665US2024409939A1Combination of oligonucleotides for modulating rtel1 and fubp1HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0759US11732262B2Use of FUBP1 inhibitors for treating hepatitis B virus infectionHOFFMANN—LA ROCHE INC·Filed 2020·Granted Aug 22, 2023·0 cites·10 claims
- 0856US2020399641A1Antisense oligonucleotides for modulating htra1 expressionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0947US10519450B2Antisense oligonucleotides for modulating HTRA1 expressionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 31, 2019·0 cites·42 claims
Join the waitlist — get patent alerts
Get an alert when Soren Ottosen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →